Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004519135 | SCV005023274 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-02-15 | criteria provided, single submitter | clinical testing | The p.S217C variant (also known as c.649A>T), located in coding exon 1 of the AXIN2 gene, results from an A to T substitution at nucleotide position 649. The serine at codon 217 is replaced by cysteine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004573469 | SCV005053132 | uncertain significance | Colorectal cancer | 2024-03-24 | criteria provided, single submitter | clinical testing |